Status:

COMPLETED

An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation

Lead Sponsor:

Forest Laboratories

Collaborating Sponsors:

Ironwood Pharmaceuticals, Inc.

Conditions:

Chronic Constipation

Irritable Bowel Syndrome With Constipation

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The objective of this study is to assess the long-term safety of linaclotide administered to patients with chronic constipation (CC) or irritable bowel syndrome with constipation (IBS-C).

Eligibility Criteria

Inclusion

  • Patients must have
  • entered study LIN-MD 01\[NCT00765882\] or LIN-MD-31 \[NCT00948818\] and at minimum completed the pre-treatment period or
  • completed one of the following studies: MCP-103-004 \[NCT00306748\], MCP-103-005 \[NCT00258193\], MCP-103-201 \[NCT00402337\], MCP-103-202 \[NCT00460811\]
  • Sexually active patients of childbearing potential agree to use birth control
  • Females of childbearing potential must have a negative urine pregnancy test prior to dosing
  • Lactating females must agree not to breastfeed
  • Patient must meet protocol criteria for CC or IBS-C

Exclusion

  • Patient must not use protocol-defined prohibited medicine
  • Patient is planning to receive an investigational drug at any time during the study
  • Patient has an unresolved AE or a clinically significant finding on a physical examination, 12-lead ECG, or clinical laboratory test

Key Trial Info

Start Date :

October 31 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 31 2012

Estimated Enrollment :

1559 Patients enrolled

Trial Details

Trial ID

NCT00765999

Start Date

October 31 2008

End Date

January 31 2012

Last Update

February 15 2019

Active Locations (118)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 30 (118 locations)

1

Innovative Clinical Trials

Birmingham, Alabama, United States, 35205

2

Parkway Medical Center

Birmingham, Alabama, United States, 35215

3

Medical Affiliated Research Center, Inc.

Huntsville, Alabama, United States, 35801

4

Radiant Research, Inc.

Chandler, Arizona, United States, 85224